arrow
S

Shelley Hall

Baylor University Medical Center
H指数:34
被引数:5,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From Rescue to Interception: The PREVENT 2-LATE (PReserve Eligibility Via Early, Necessary Transfer) Framework for Advanced Heart Failure

从救援到拦截:PREVENT 2-LATE(通过早期必要转移保留资格)框架用于治疗心力衰竭

2026-08-270
PRE
Towards an Understanding of Best Practice – The Good, The Bad and the Future of Cardiogenic Shock Teams

迈向对最佳实践的理解——心血管休克团队的优势、不足及未来

2025-11-220
PRE
Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study

在前瞻性、观察性研究中,定义用于评估心脏移植中抗体介导排斥反应的四种测试之间的关系。

2025-11-130
OAAI
Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection

供者源性细胞游离DNA在抗体介导型排斥反应中

2025-10-220
OAAI
Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation

移植前接受持久左心室辅助装置支持患者的原发移植物功能障碍

2025-10-110
PRE
Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force

关于克服移植专科培训障碍的建议:美国移植学会专科医师工作组报告

2025-05-130
PRE
The 2023 American College of Cardiology Advanced Heart Failure Staffing Survey The Report From the ACC Council on Heart Failure and Transplantation

2023年美国心脏病学会心力衰竭高级阶段人员配置调查报告——美国心脏病学会心力衰竭与移植委员会的报告

2025-05-010
PRE
Regional differences in primary graft dysfunction: A report from the international consortium on PGD

移植后早期移植物功能不全的区域差异:国际PGD联盟的报告

2025-03-060
PRE
Prognostic Implications of Quantifying Vasoactive Medications in Cardiogenic Shock
2024-11-010
PRE
Association of Hemometabolic Trajectory and Mortality: Insights From the Cardiogenic Shock Working Group Registry
2024-10-011
PRE
Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry
2024-09-014
OAAI